Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 10, 2021
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
[ Wed, Mar 10th 2021
] - WOPRAI
Tue, March 9, 2021
[ Tue, Mar 09th 2021
] - WOPRAI
David Nierengarten Downgraded (ANAB) to Hold on, Mar 9th, 2021
David Nierengarten of Wedbush, Downgraded "AnaptysBio, Inc." (ANAB) to Hold on, Mar 9th, 2021.
David has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Anupam Rama of "JP Morgan" Upgraded from Sell to Buy and Increased Target to $40 on, Thursday, February 11th, 2021
